SCHEMBL5850647

SCHEMBL5850647

Cc1ccc(S(=O)(=O)N(C(=O)[C@@H]2CCCN2)[C@@](C)(Cc2ccc(OC(=O)N3CCOCC3)cc2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
NPY2R P49146 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GAA P10253 2/20 0.35
ALDH1A1 P00352 2/20 0.35
BMP1 P13497 1/20 0.33
STAT3 P40763 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850848 0.92 L3MBTL1 (0.36) L3MBTL1NPY2RMEN1KMT2AALDH1A1
SCHEMBL5852560 0.92 CYP2C9 (0.45) CYP1A2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL5851162 0.91 CYP2C9 (0.41) CYP1A2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL5852329 0.86 PTGES (0.33) RAB9AMEN1KMT2AALDH1A1STAT3
SCHEMBL5852564 0.84 NPY2R (0.38) CYP1A2CYP2C9CYP2C19L3MBTL1NPY2R
SCHEMBL5850900 0.83 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL5850614 0.83 PTGES (0.31) STAT3
SCHEMBL5852118 0.80 PSEN1 (0.35) RAB9AMEN1KMT2AGAAALDH1A1
SCHEMBL7451631 0.78 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19RAB9AL3MBTL1
SCHEMBL5850585 0.77 PTGES (0.36) RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP claimed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed